| Human dendritic cell subsets: an update |
126 |
| Improved methods for predicting peptide binding affinity to MHC class II molecules |
88 |
| Inflammation in CNS neurodegenerative diseases |
82 |
| Properties and functions of adipose tissue macrophages in obesity |
71 |
| Immune regulation by microbiome metabolites |
39 |
| VSIG-3 as a ligand of VISTA inhibits human T-cell function |
33 |
| Impacts of microbiome metabolites on immune regulation and autoimmunity |
33 |
| Immune modulatory effects of statins |
32 |
| Implications of macrophage polarization in autoimmunity |
28 |
| Hypoxia and acidosis: immune suppressors and therapeutic targets |
26 |
| Adaptive immune education by gut microbiota antigens |
26 |
| Macrophage targeting: opening new possibilities for cancer immunotherapy |
25 |
| Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry |
22 |
| Impact of sex hormones on immune function and multiple sclerosis development |
22 |
| Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures? |
20 |
| Cancer stem cells as targets for immunotherapy |
20 |
| Novel viral vectors in infectious diseases |
19 |
| Recent advances on the crosstalk between neutrophils and B or T lymphocytes |
19 |
| Interleukin-17-producing gamma delta T (gamma delta 17) cells in inflammatory diseases |
19 |
| Natural killer cell cytotoxicity and its regulation by inhibitory receptors |
16 |
| The role of transforming growth factor in T helper 17 differentiation |
15 |
| A Hitchhiker's guide to humanized mice: new pathways to studying viral infections |
14 |
| Origins of CD4(+) circulating and tissue-resident memory T-cells |
14 |
| Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6 |
14 |
| Infectious processes and systemic lupus erythematosus |
14 |
| Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome |
13 |
| Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity |
13 |
| MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease |
13 |
| Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective |
12 |
| Autoimmunity and autoimmune co-morbidities in psoriasis |
12 |
| Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes |
12 |
| Antibody repertoire analysis in polygenic autoimmune diseases |
12 |
| Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus |
12 |
| Systems vaccinology and big data in the vaccine development chain |
12 |
| HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis |
11 |
| Selected signalling proteins recruited to the T-cell receptor-CD3 complex |
11 |
| Helios: still behind the clouds |
11 |
| Cancer immune escape: MHC expression in primary tumours versus metastases |
10 |
| Dissecting human ILC heterogeneity: more than just three subsets |
10 |
| The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders |
10 |
| Developmental origins of murine T-cell subsets |
10 |
| A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens |
10 |
| Endoplasmic reticulum stress induced LOX-1(+)CD15(+) polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma |
10 |
| The IL-13-OVOL1-FLG axis in atopic dermatitis |
10 |
| The inflammasomes, immune guardians at defence barriers |
10 |
| Development of a novel clustering tool for linear peptide sequences |
10 |
| Updates on T helper type 17 immunity in respiratory disease |
10 |
| Alemtuzumab depletion failure can occur in multiple sclerosis |
9 |
| Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering |
9 |
| Comparative analysis of murine T-cell receptor repertoires |
9 |
